drugset / Trial / NCT00307411

Effect of Growth Hormone in Metabolic Syndrome

NCT00307411

Phase 4 Unknown 32 enrolled Chinese University of Hong Kong
RandomizedParallel-groupDouble-blindTreatment

Summary

Investigating the effect of low dose growth hormone therapy on body fat composition, insulin sensitivity and metabolic profiles in middle-aged men with metabolic syndrome and low insulin-like growth factor (IGF-1) level.

Timeline

Start
2006-08
Primary completion
Completion
2007-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Somatropin Protein / enzyme biologic

Indications